麻豆传媒

• share
• favorite_border

Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world鈥檚 deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab.

• share
• favorite_border

A new study led by researchers at Albert Einstein College of Medicine involving more than 200,000 adults found that the COVID-19 pandemic caused a 29% increase in risk for developing dyslipidemia, a condition involving abnormal lipid (fat) levels in the blood. Seniors and people with type 2 diabetes were even more strongly affected, experiencing an approximately two-fold increased risk for developing dyslipidemia, which is a major risk factor for cardiovascular diseases such as heart attack and stroke. The research was published today in the print edition of The Journal of Clinical Investigation.

• share
• favorite_border

Stem cell researcher Teresa Bowman, Ph.D., has been appointed chair of the department of developmental & molecular biology (DMB) at Albert Einstein College of Medicine after a comprehensive national search. Dr. Bowman will begin her new role on December 1, following the longtime leadership of Richard Stanley, Ph.D.

• share
• favorite_border

A research team at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has discovered a natural immune mechanism in mice that stops escaped cancer cells from developing into tumors elsewhere in the body. The findings were published today in the journal Cell.

• share
• favorite_border

The National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. Xingxing Zang, Ph.D., an international leader in developing novel immunotherapies, has been named its inaugural director.

• share
• favorite_border

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID鈥檚 new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.

• share
• favorite_border

A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body鈥檚 different blood cells.

• share
• favorite_border

After an extensive national search, Jessica Kahn, M.D., M.P.H., has been appointed as the senior associate dean for clinical and translational research and director of the Block Institute for Clinical and Translational Research (ICTR) at Albert Einstein College of Medicine. She currently serves as co-director of the Center for Clinical and Translational Science and Training (CCTST) and professor of pediatrics at the University of Cincinnati and as the founding associate chair of academic affairs and career development at Cincinnati Children鈥檚. Dr. Kahn will begin her new role at Einstein on October 21.

• share
• favorite_border

The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine.

• share
• favorite_border

Marla Keller, M.D., a national leader in academic medicine and in clinical and translational research and training, has been appointed executive dean at Albert Einstein College of Medicine.

• share
• favorite_border

Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors鈥攁n advance that could transform cancer treatment. The promising findings, reported today in Science Advances, involve CAR-T cell therapy, which supercharges the immune system to identify and attack cancer cells.

• share
• favorite_border

Albert Einstein College of Medicine has appointed nationally recognized education leader Yoon Kang, M.D., as its inaugural vice dean for education, following a national search.

• share
• favorite_border

Just as you can鈥檛 make an omelet without breaking eggs, scientists at Albert Einstein College of Medicine have found that you can鈥檛 make long-term memories without DNA damage and brain inflammation. Their surprising findings were published online today in the journal Nature.

• share
• favorite_border

As we age, our hematopoietic (blood-forming) stem cells (HSCs) become less able to produce new red and white blood cells and other vital blood components鈥攃ontributing to chronic inflammation and accelerating the onset of blood cancers and degenerative diseases.

• share
• favorite_border

Montefiore Health System and Albert Einstein College of Medicine have been awarded a $1.5 million National Institutes of Health grant to provide advanced research training to post-graduate trainees from groups that are underrepresented in medicine and have research interests in heart, lung, blood, and sleep disorders. Over five years, nine researchers will receive intense research training and robust mentorship from almost 30 established, senior investigators across Montefiore and Einstein.

• share
• favorite_border

Neurologists often diagnose Alzheimer鈥檚 disease after evaluating patients during lengthy, in-person office visits.

• share
• favorite_border

Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)鈥攖wo related blood diseases that disproportionally strike older adults鈥攁re notoriously difficult to treat and associated with high relapse rates.

• share
• favorite_border

The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI) of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S.

• share
• favorite_border

Yaron Tomer, MD, has been named the Marilyn and Stanley M. Katz Dean at the Albert Einstein College of Medicine, effective October 2nd, 2023. Following a comprehensive national search, Dr. Tomer stood out as the clear choice to lead the College of Medicine amongst a group of highly accomplished and distinguished candidates.

• share
• favorite_border

In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss. The findings published online today in the Journal of the National Cancer Institute (JNCI).